Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FSHR | P23945 | 17/20 | 0.86 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3396723 | 0.94 | FSHR (0.80) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL1322857 | 0.93 | FSHR (0.78) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL5728539 | 0.93 | FSHR (0.78) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL1322285 | 0.92 | FSHR (1.00) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL3392106 | 0.91 | FSHR (0.75) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL4600825 | 0.86 | FSHR (0.68) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL3433337 | 0.86 | FSHR (0.68) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL3393050 | 0.85 | FSHR (0.67) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL17209734 | 0.84 | FSHR (0.66) | FSHRTSHRMEN1ADRB2KMT2A | |
| SCHEMBL3393047 | 0.84 | FSHR (0.66) | FSHRTSHRMEN1ADRB2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1406628-B1 | TETRAHYDROQUINOLINE DERIVATIVES | AKZO NOBEL NV (NL) | 2006-03-08 | — | — | EP | claimed |
| EP-1406628-B1 | TETRAHYDROQUINOLINE DERIVATIVES | AKZO NOBEL NV (NL) | 2006-03-08 | — | — | EP | disclosed |